SCRI-IS Technologies Ltd is a specialized engineering firm at the forefront of asset reliability, providing mission-critical support to global mission-critical sectors, including biotechnology manufacturing and data centre operations. Operating from the state-of-the-art Callan Laboratory in Dublin, the company bridges the gap between complex engineering maintenance and operational continuity. By ensuring that production assets in highly regulated cGMP environments perform at peak efficiency, SCRI-IS empowers life-science manufacturers to meet their ultimate objective: maximizing the consistent and safe delivery of medicines to patients.

As a trusted technical partner to 52 multinational pharmaceutical companies. The company’s 100% independent, ISO-certified service model is built on a foundation of "Engineering Resilience”. This involves moving manufacturing sites from reactive maintenance to data-driven, predictive strategies, a shift that is essential for maintaining Ireland’s competitive edge as a global hub for high-tech pharmaceutical production. As part of our strategic direction, SCRI-IS is expanding its focus towards Industry 4.0, developing digital solutions that leverage data, advanced analytics, and AI to enhance asset performance and enable more informed, data-driven decision-making within regulated manufacturing environments.

Alongside our work in life sciences, SCRI-IS is expanding its asset reliability and performance services into the data centre sector, applying the same focus on critical infrastructure, operational continuity, and operational resilience.

Beyond operational uptime, SCRI-IS is a key driver of the industry’s Green Transition. By optimising the lifecycle of critical components, the firm significantly reduces plastic and material waste streams that would otherwise enter landfills. This focus on sustainability is paired with a commitment to the Irish talent ecosystem; by employing and upskilling specialized engineers, SCRI-IS ensures that high-value technical intellectual property remains anchored within the state, supporting the long-term resilience of the national manufacturing base.

Why work with us

SCRI-IS is a specialist asset reliability and performance company serving the global biopharmaceutical and life sciences sector.

We help manufacturers maximise uptime, reduce operational risk, improve sustainability, and optimise maintenance strategies across critical production assets. Our work enables clients to make better decisions about asset performance, maintenance investment, and lifecycle management while maintaining the highest standards of quality and compliance.

In highly regulated manufacturing environments, unplanned downtime, unnecessary maintenance, and inefficient asset management can result in significant operational and financial costs. SCRI-IS helps organisations move beyond assumption-based decision making by providing the evidence, insight, and expertise needed to improve reliability and performance across their facilities.

Our team combines deep industry knowledge with advanced testing, engineering, and data-driven methodologies to identify opportunities for improved asset availability, reduced maintenance burden, lower waste generation, and more effective use of operational resources.

Clients choose SCRI-IS because we focus on outcomes rather than activities. We help organisations reduce downtime, extend asset life, optimise maintenance programmes, improve sustainability performance, and make technically robust decisions that stand up to regulatory scrutiny.

Working with leading biopharmaceutical manufacturers globally, SCRI-IS has delivered measurable results including significant reductions in maintenance costs, increased asset availability, reduced material waste, improved engineering productivity, and enhanced operational resilience.

The same reliability principles and engineering expertise are increasingly being applied within data centre environments, where asset performance and operational continuity are equally critical.

Our mission is simple: to help our clients operate more efficiently, more sustainably, and with greater confidence in the performance of their critical assets.